BIAF
Price
$0.75
Change
-$0.14 (-15.73%)
Updated
Apr 3, 02:28 PM (EDT)
Capitalization
23.27M
47 days until earnings call
RSLS
Price
$0.41
Change
-$0.04 (-8.89%)
Updated
Apr 3, 01:13 PM (EDT)
Capitalization
4.33M
Ad is loading...

BIAF vs RSLS

Header iconBIAF vs RSLS Comparison
Open Charts BIAF vs RSLSBanner chart's image
bioAffinity Technologies
Price$0.75
Change-$0.14 (-15.73%)
Volume$100
Capitalization23.27M
ReShape Lifesciences
Price$0.41
Change-$0.04 (-8.89%)
Volume$1.66K
Capitalization4.33M
BIAF vs RSLS Comparison Chart
Loading...
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIAF vs. RSLS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIAF is a Hold and RSLS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BIAF: $0.89 vs. RSLS: $0.45)
Brand notoriety: BIAF and RSLS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIAF: 229% vs. RSLS: 857%
Market capitalization -- BIAF: $23.27M vs. RSLS: $4.33M
BIAF [@Medical Specialties] is valued at $23.27M. RSLS’s [@Medical Specialties] market capitalization is $4.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIAF’s FA Score shows that 0 FA rating(s) are green whileRSLS’s FA Score has 0 green FA rating(s).

  • BIAF’s FA Score: 0 green, 5 red.
  • RSLS’s FA Score: 0 green, 5 red.
According to our system of comparison, BIAF is a better buy in the long-term than RSLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIAF’s TA Score shows that 4 TA indicator(s) are bullish while RSLS’s TA Score has 1 bullish TA indicator(s).

  • BIAF’s TA Score: 4 bullish, 4 bearish.
  • RSLS’s TA Score: 1 bullish, 5 bearish.
According to our system of comparison, BIAF is a better buy in the short-term than RSLS.

Price Growth

BIAF (@Medical Specialties) experienced а +213.38% price change this week, while RSLS (@Medical Specialties) price change was -4.72% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.24%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +2.42%.

Reported Earning Dates

BIAF is expected to report earnings on May 20, 2025.

RSLS is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Medical Specialties (-3.24% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIAF($23.3M) has a higher market cap than RSLS($4.33M). BIAF YTD gains are higher at: -2.198 vs. RSLS (-89.910). BIAF has higher annual earnings (EBITDA): -7.01M vs. RSLS (-36.72M). BIAF has more cash in the bank: 4.51M vs. RSLS (1.45M). RSLS has less debt than BIAF: RSLS (285K) vs BIAF (1.69M). RSLS has higher revenues than BIAF: RSLS (9.81M) vs BIAF (321K).
BIAFRSLSBIAF / RSLS
Capitalization23.3M4.33M539%
EBITDA-7.01M-36.72M19%
Gain YTD-2.198-89.9102%
P/E RatioN/AN/A-
Revenue321K9.81M3%
Total Cash4.51M1.45M311%
Total Debt1.69M285K592%
FUNDAMENTALS RATINGS
RSLS: Fundamental Ratings
RSLS
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIAFRSLS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENSC2.640.14
+5.60%
Ensysce Biosciences
DHX1.350.03
+2.27%
DHI Group
CBU57.520.67
+1.18%
Community Financial System Inc
UDR45.360.19
+0.42%
UDR
ATEX36.62-0.03
-0.08%
Anterix

BIAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIAF has been loosely correlated with RSLS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BIAF jumps, then RSLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIAF
1D Price
Change %
BIAF100%
-18.35%
RSLS - BIAF
56%
Loosely correlated
-71.70%
SNWV - BIAF
32%
Poorly correlated
-10.50%
HSCS - BIAF
29%
Poorly correlated
+1.82%
RDNT - BIAF
26%
Poorly correlated
+3.73%
TRXO - BIAF
25%
Poorly correlated
N/A
More